Analgesics Market is expected to reach USD 70.73 billion by 2029

According to the National Institute of Health, 20% of adults in the United States suffer from chronic pain, with 8% having high-impact chronic pain. According to a National Center for Health Statistics research covering the last decade, one out of every four Americans has experienced pain that lasts more than a day. Pain management has become a key issue for healthcare practitioners all over the world as the incidence of arthritis and acute chronic diseases rises. The demand for analgesics and painkillers is increasing as a result of these advancements.

Data Bridge Market Research analyses that the analgesics market was valued at USD 49.02 billion in 2021 and is expected to reach USD 70.73 billion by 2029, registering a CAGR of 4.69% during the forecast period of 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Read More:
https://www.databridgemarketresearch.com/reports/global-analgesics-market

Market Definition

Analgesics, often known as painkillers or pain relievers, are medications that serve to reduce pain without altering awareness, sensory perception, or nerve impulse conduction. Paracetamol (acetaminophen), nonsteroidal anti-inflammatory drugs (NSAIDs) including salicylates, and opioids such as morphine and oxycodone are among these pharmaceuticals. Pain from physiological injuries, operations, phantom aches, inflammation, neuropathic diseases, and cancer treatments are all treated with analgesics.

Recent Acquisition

In July 2021, Heron Therapeutics Inc. had announced the launch of ZYNRELEF. It's an extended-release solution for soft tissue or periarticular installation in adults to provide postsurgical analgesia for up to 72 hours following a bunionectomy, open inguinal herniorrhaphy, or total knee arthroplasty.

Some of the major players operating in the analgesics market are:

F. Hoffmann-La Roche Ltd. (Switzerland)
Mylan N.V. (U.S.)
Teva Pharmaceutical Industries Ltd. (Ireland)
Sanofi (France)
Pfizer Inc. (U.S.)
GlaxoSmithKline plc (U.K.)
Novartis AG (Switzerland)
Merck & Co., Inc. (U.S.)
AstraZeneca (U.K.)
Johnson & Johnson Private Limited (U.S.)
Hikma Pharmaceuticals PLC (U.K.)
Dr. Reddy's Laboratories Ltd. (India)
Fresenius Kabi AG (Germany)
Aurobindo Pharma (India)
Bausch Health Companies Inc. (Canada)
Amneal Pharmaceuticals LLC. (U.S.)
Apotex Inc. (Canada)
Eli Lilly and Company (U.S.)
Cipla Inc. (U.S.)
Lupin (India)

More Links:

https://dbmrbuisness.blogspot.com/2023/07/global-viral-hepatitis-market-industry.html

https://dbmrbuisness.blogspot.com/2023/07/global-surgical-simulator-market.html

https://dbmrbuisness.blogspot.com/2023/07/global-neuromyelitis-optica-spectrum.html

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact Us:-
Data Bridge Market research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

This release was published on openPR.